Numbers of non-squamous NSCLC patients, patients tested for EGFR mutations, and EGFR mutation-positive patients shown by age, gender, ethnicity and smoking status in northern New Zealand, between 1 February 2010 and 31 July 2017. This evidence concerns the gene EGFR and non-small cell lung carcinoma.